,Tumor State,Gene Signature,MWU-BH p-value,MWU-BH-LOOCV p-value,GLM p-value,GLM-LOOCV p-value,Pseudobulk p-value,Pseudobulk-LOOCV p-value
1,Tumor State 1,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.037,0.042
2,Tumor State 1,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.0844,0.0908
3,Tumor State 1,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.5037,0.495
4,Tumor State 1,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.1403,0.143
5,Tumor State 1,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.1772,0.1939
6,Tumor State 1,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.0663,0.0791
7,Tumor State 1,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.3378,0.3331
8,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0,0.0,0.0,0.0,0.1511,0.1661
9,Tumor State 1,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.0663,0.0699
10,Tumor State 1,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.0552,0.0666
11,Tumor State 1,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.0844,0.1058
13,Tumor State 1,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.2064,0.2072
15,Tumor State 1,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.0663,0.0791
16,Tumor State 1,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.1432,0.1526
17,Tumor State 1,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.1403,0.1475
18,Tumor State 1,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.2002,0.2145
19,Tumor State 1,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.4218,0.4573
20,Tumor State 1,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0,0.0,0.0,0.0,0.1403,0.1526
21,Tumor State 1,PAM50,0.0,0.0,0.0,0.0,0.1718,0.1886
22,Tumor State 1,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.0023,0.0034
23,Tumor State 1,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.1469,0.164
24,Tumor State 1,WU_ET_AL_LUMA_SC,0.0,0.0,0.0001,0.0001,0.5011,0.4872
25,Tumor State 1,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.3675,0.3913
26,Tumor State 1,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.3172,0.308
27,Tumor State 1,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.0169,0.0216
28,Tumor State 1,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.121,0.1327
29,Tumor State 1,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.0796,0.1005
30,Tumor State 1,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.0373,0.0465
31,Tumor State 1,HALLMARK_APICAL_SURFACE,0.0004,0.0003,0.0,0.0,0.2721,0.2895
32,Tumor State 1,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.184,0.1814
34,Tumor State 1,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.0158,0.0193
35,Tumor State 1,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.0169,0.0224
36,Tumor State 1,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.0083,0.0116
37,Tumor State 1,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.3305,0.3621
38,Tumor State 1,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.0515,0.0646
39,Tumor State 1,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.0233,0.0288
40,Tumor State 1,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0,0.0,0.0,0.0,0.031,0.041
41,Tumor State 1,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0,0.0,0.0,0.0,0.2721,0.2962
42,Tumor State 1,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.4203,0.397
43,Tumor State 1,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.1387,0.1646
44,Tumor State 1,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.0465,0.0581
45,Tumor State 1,HALLMARK_HEDGEHOG_SIGNALING,0.0,0.0,0.0,0.0,0.1962,0.2226
46,Tumor State 1,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.0258,0.0317
47,Tumor State 1,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.0036,0.0047
48,Tumor State 1,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.0071,0.0097
49,Tumor State 1,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.004,0.0056
50,Tumor State 1,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.004,0.0053
52,Tumor State 1,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.0019,0.0027
53,Tumor State 1,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.1387,0.164
54,Tumor State 1,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.0186,0.0245
55,Tumor State 1,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.4203,0.3937
56,Tumor State 1,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.4551,0.4532
57,Tumor State 1,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.0158,0.02
58,Tumor State 1,HALLMARK_NOTCH_SIGNALING,0.3106,0.3395,0.0359,0.0444,0.1305,0.1364
59,Tumor State 1,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.3834,0.3987
60,Tumor State 1,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.004,0.0055
61,Tumor State 1,HALLMARK_PANCREAS_BETA_CELLS,0.0064,0.0095,0.0,0.0,0.3305,0.3439
62,Tumor State 1,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.2878,0.2852
63,Tumor State 1,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.0948,0.1139
64,Tumor State 1,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.2089,0.2017
65,Tumor State 1,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.2721,0.276
66,Tumor State 1,HALLMARK_SPERMATOGENESIS,0.0002,0.0001,0.0,0.0,0.2453,0.2686
67,Tumor State 1,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.15,0.1733
68,Tumor State 1,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.0019,0.0027
69,Tumor State 1,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.2453,0.2433
70,Tumor State 1,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.086,0.1111
71,Tumor State 1,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.0284,0.0348
72,Tumor State 1,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0004,0.0006,0.0,0.0001,0.0796,0.0897
73,Tumor State 1,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.4891,0.4319
74,Tumor State 1,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0,0.0,0.0019,0.0027
75,Tumor State 1,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.0106,0.0136
76,Tumor State 1,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0,0.0,0.0,0.0,0.0169,0.0232
77,Tumor State 1,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.0027,0.0036
79,Tumor State 1,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.0079,0.0104
80,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.0071,0.0096
81,Tumor State 1,ONCOGENIC_ATF2_S_UP.V1_UP,0.0,0.0,0.0,0.0,0.0106,0.0142
82,Tumor State 1,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.0068,0.0085
83,Tumor State 1,ONCOGENIC_ATF2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0014,0.0019
84,Tumor State 1,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0,0.031,0.0368
85,Tumor State 1,ONCOGENIC_ATM_DN.V1_UP,0.0002,0.0001,0.0087,0.0056,0.0681,0.084
86,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_DN,0.0001,0.0001,0.0,0.0,0.0629,0.0764
87,Tumor State 1,ONCOGENIC_BCAT.100_UP.V1_UP,0.0,0.0,0.0,0.0,0.0211,0.0269
88,Tumor State 1,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0,0.0,0.0,0.0,0.2316,0.2339
89,Tumor State 1,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0,0.0,0.0,0.0,0.2316,0.2365
90,Tumor State 1,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0,0.0,0.0,0.3651,0.3541
91,Tumor State 1,ONCOGENIC_BCAT_GDS748_UP,0.0,0.0,0.0,0.0,0.0373,0.0489
92,Tumor State 1,ONCOGENIC_BMI1_DN.V1_DN,0.0,0.0,0.0,0.0,0.3651,0.3884
93,Tumor State 1,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.004,0.0054
94,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.086,0.097
95,Tumor State 1,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.0019,0.0026
96,Tumor State 1,ONCOGENIC_BRCA1_DN.V1_DN,0.0,0.0,0.0,0.0,0.1387,0.1676
97,Tumor State 1,ONCOGENIC_BRCA1_DN.V1_UP,0.0676,0.0596,0.0224,0.0245,0.3172,0.3274
98,Tumor State 1,ONCOGENIC_CAHOY_ASTROCYTIC,0.0,0.0,0.0,0.0,0.0026,0.0033
99,Tumor State 1,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.004,0.0052
100,Tumor State 1,ONCOGENIC_CAHOY_NEURONAL,0.0,0.0,0.0,0.0,0.3834,0.3804
102,Tumor State 1,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.0233,0.0291
103,Tumor State 1,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.2316,0.2391
104,Tumor State 1,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0,0.0,0.004,0.0056
105,Tumor State 1,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.0014,0.0019
106,Tumor State 1,ONCOGENIC_CRX_DN.V1_UP,0.0022,0.0028,0.0915,0.1023,0.3172,0.341
107,Tumor State 1,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0063,0.0053,0.0063,0.005,0.1962,0.1983
108,Tumor State 1,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0,0.0,0.0,0.0,0.15,0.1646
109,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.184,0.1959
110,Tumor State 1,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.0681,0.0817
111,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.0419,0.0527
112,Tumor State 1,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.15,0.1729
113,Tumor State 1,ONCOGENIC_CTIP_DN.V1_DN,0.0128,0.012,0.1533,0.1356,0.3054,0.3022
114,Tumor State 1,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.0011,0.0011,0.3305,0.3525
115,Tumor State 1,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0,0.0,0.0,0.0,0.0948,0.1035
116,Tumor State 1,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.0629,0.0747
117,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.0079,0.0104
118,Tumor State 1,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0,0.0,0.0,0.0,0.0083,0.0113
119,Tumor State 1,ONCOGENIC_DCA_UP.V1_DN,0.0437,0.0377,0.2556,0.2159,0.4368,0.4636
120,Tumor State 1,ONCOGENIC_DCA_UP.V1_UP,0.0,0.0,0.0,0.0,0.121,0.1356
121,Tumor State 1,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.0124,0.0153
122,Tumor State 1,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.0796,0.0948
125,Tumor State 1,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0,0.0,0.0796,0.0994
126,Tumor State 1,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.0014,0.0019
127,Tumor State 1,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0008,0.0013,0.0419,0.0531
128,Tumor State 1,ONCOGENIC_EIF4E_UP,0.0,0.0,0.0,0.0,0.2089,0.2143
129,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_DN,0.0076,0.0091,0.066,0.0789,0.1589,0.1861
130,Tumor State 1,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0083,0.0108
131,Tumor State 1,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.0233,0.0298
132,Tumor State 1,ONCOGENIC_ESC_J1_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.2592,0.2516
133,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.0139,0.0185
134,Tumor State 1,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.0169,0.0224
135,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.0036,0.0049
136,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.1387,0.1427
137,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.004,0.0056
138,Tumor State 1,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.0373,0.0442
139,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.0083,0.0112
140,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0,0.0002,0.0003,0.121,0.133
141,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.0139,0.0183
142,Tumor State 1,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.0465,0.0572
143,Tumor State 1,ONCOGENIC_GLI1_UP.V1_DN,0.0003,0.0002,0.0007,0.0004,0.4368,0.4749
144,Tumor State 1,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0,0.0,0.0258,0.0317
145,Tumor State 1,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.0043,0.0061
146,Tumor State 1,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.057,0.0674
147,Tumor State 1,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.0068,0.0087
148,Tumor State 1,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.0083,0.0114
149,Tumor State 1,ONCOGENIC_IL15_UP.V1_DN,0.4679,0.385,0.0438,0.0295,0.1589,0.1793
150,Tumor State 1,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.0629,0.0764
152,Tumor State 1,ONCOGENIC_IL21_UP.V1_UP,0.0,0.0,0.0,0.0,0.0284,0.0366
153,Tumor State 1,ONCOGENIC_IL2_UP.V1_DN,0.0,0.0,0.0,0.0,0.2592,0.276
154,Tumor State 1,ONCOGENIC_IL2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0093,0.0131
155,Tumor State 1,ONCOGENIC_JAK2_DN.V1_DN,0.0,0.0,0.0,0.0,0.086,0.1042
156,Tumor State 1,ONCOGENIC_JAK2_DN.V1_UP,0.0,0.0,0.0,0.0,0.3305,0.3556
157,Tumor State 1,ONCOGENIC_JNK_DN.V1_DN,0.0,0.0,0.0,0.0,0.1305,0.1446
158,Tumor State 1,ONCOGENIC_JNK_DN.V1_UP,0.0,0.0,0.0,0.0,0.0465,0.0562
159,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.0681,0.0805
160,Tumor State 1,ONCOGENIC_KRAS.300_UP.V1_UP,0.0039,0.0083,0.2392,0.3222,0.0373,0.0469
161,Tumor State 1,ONCOGENIC_KRAS.50_UP.V1_DN,0.0,0.0,0.0,0.0,0.0737,0.0875
162,Tumor State 1,ONCOGENIC_KRAS.50_UP.V1_UP,0.0489,0.0715,0.0054,0.0108,0.0737,0.0868
163,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0006,0.0007,0.0002,0.0005,0.086,0.1012
164,Tumor State 1,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.1487,0.1327,0.0017,0.0022,0.086,0.1088
165,Tumor State 1,ONCOGENIC_KRAS.600_UP.V1_DN,0.0,0.0,0.0,0.0,0.0737,0.0874
167,Tumor State 1,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.1137,0.1239
169,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.222,0.2383
170,Tumor State 1,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.031,0.0406
171,Tumor State 1,ONCOGENIC_KRAS.DF.V1_DN,0.0,0.0,0.0,0.0,0.031,0.0389
172,Tumor State 1,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.0258,0.0317
173,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0,0.0,0.0,0.0,0.0681,0.0767
174,Tumor State 1,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0,0.0,0.0,0.0,0.0233,0.0295
175,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0162,0.0124,0.9673,0.649,0.4203,0.4225
176,Tumor State 1,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0757,0.0814,0.0235,0.025,0.1732,0.1751
177,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.0071,0.0096
178,Tumor State 1,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0,0.0,0.0042,0.0041,0.2592,0.2905
179,Tumor State 1,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.0068,0.0085
181,Tumor State 1,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.2878,0.288
182,Tumor State 1,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.0051,0.0062
183,Tumor State 1,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.057,0.0689
184,Tumor State 1,ONCOGENIC_LTE2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0071,0.0094
185,Tumor State 1,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.4732,0.4577
186,Tumor State 1,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.0027,0.0038
187,Tumor State 1,ONCOGENIC_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.222,0.223
188,Tumor State 1,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.0139,0.019
189,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.3172,0.3246
190,Tumor State 1,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.0169,0.0209
191,Tumor State 1,ONCOGENIC_MTOR_UP.V1_DN,0.0,0.0,0.0,0.0,0.004,0.0056
192,Tumor State 1,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.1305,0.1507
193,Tumor State 1,ONCOGENIC_MYC_UP.V1_DN,0.0002,0.0001,0.0026,0.002,0.1305,0.1436
194,Tumor State 1,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.1962,0.2086
195,Tumor State 1,ONCOGENIC_NFE2L2.V2,0.0,0.0,0.0,0.0,0.0284,0.0372
196,Tumor State 1,ONCOGENIC_NOTCH_DN.V1_DN,0.0,0.0,0.0,0.0,0.0353,0.0428
197,Tumor State 1,ONCOGENIC_NOTCH_DN.V1_UP,0.0564,0.0488,0.1462,0.1185,0.0796,0.0948
199,Tumor State 1,ONCOGENIC_NRL_DN.V1_UP,0.0656,0.0723,0.0088,0.0112,0.2316,0.2503
200,Tumor State 1,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.0033,0.0044
201,Tumor State 1,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.0083,0.0112
202,Tumor State 1,ONCOGENIC_P53_DN.V2_DN,0.0,0.0,0.003,0.0032,0.2316,0.2544
203,Tumor State 1,ONCOGENIC_P53_DN.V2_UP,0.0,0.0,0.0,0.0,0.0043,0.006
204,Tumor State 1,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0013,0.0017,0.0008,0.001,0.184,0.1764
205,Tumor State 1,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.1589,0.1707
206,Tumor State 1,ONCOGENIC_PDGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.1043,0.1111
207,Tumor State 1,ONCOGENIC_PDGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.1137,0.1181
208,Tumor State 1,ONCOGENIC_PIGF_UP.V1_DN,0.0041,0.0048,0.0144,0.0171,0.121,0.1256
210,Tumor State 1,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.0186,0.0249
211,Tumor State 1,ONCOGENIC_PKCA_DN.V1_UP,0.0023,0.0027,0.0025,0.0032,0.4203,0.4281
212,Tumor State 1,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.298,0.2658,0.0424,0.0534,0.222,0.223
213,Tumor State 1,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0,0.0,0.0,0.0,0.0071,0.0097
214,Tumor State 1,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0,0.0,0.0,0.0,0.1137,0.1345
215,Tumor State 1,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0,0.0,0.0,0.0,0.0211,0.0271
216,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0027,0.0026,0.0,0.0,0.1589,0.1676
217,Tumor State 1,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0,0.0,0.0,0.0,0.0093,0.0129
218,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0059,0.0067,0.0407,0.0377,0.4891,0.4333
219,Tumor State 1,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.463,0.3806,0.8345,0.6951,0.0373,0.048
220,Tumor State 1,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.004,0.0054
221,Tumor State 1,ONCOGENIC_PTEN_DN.V1_UP,0.0001,0.0001,0.0,0.0,0.1962,0.2086
222,Tumor State 1,ONCOGENIC_PTEN_DN.V2_DN,0.0,0.0,0.0,0.0001,0.0737,0.0868
223,Tumor State 1,ONCOGENIC_PTEN_DN.V2_UP,0.0,0.0,0.0,0.0,0.0093,0.0129
224,Tumor State 1,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.057,0.072
225,Tumor State 1,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.0014,0.0019
226,Tumor State 1,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.184,0.1894
227,Tumor State 1,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.2453,0.2686
228,Tumor State 1,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.1387,0.1274
229,Tumor State 1,ONCOGENIC_RB_DN.V1_UP,0.0,0.0,0.0,0.0,0.1589,0.1531
230,Tumor State 1,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.0373,0.0456
231,Tumor State 1,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.0186,0.0226
232,Tumor State 1,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.031,0.038
233,Tumor State 1,ONCOGENIC_RB_P130_DN.V1_UP,0.0,0.0,0.0,0.0,0.222,0.2242
236,Tumor State 1,ONCOGENIC_RPS14_DN.V1_DN,0.0,0.0,0.0,0.0,0.0515,0.0586
237,Tumor State 1,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.0033,0.0044
238,Tumor State 1,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0043,0.0028,0.2316,0.2391
239,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.0079,0.0102
240,Tumor State 1,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.0737,0.0861
241,Tumor State 1,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.0031,0.0043
242,Tumor State 1,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.0019,0.0026
243,Tumor State 1,ONCOGENIC_SRC_UP.V1_DN,0.0,0.0,0.0006,0.0006,0.121,0.1191
244,Tumor State 1,ONCOGENIC_SRC_UP.V1_UP,0.0,0.0,0.0,0.0,0.3172,0.3439
245,Tumor State 1,ONCOGENIC_STK33_DN,0.0,0.0,0.0,0.0,0.0169,0.0235
246,Tumor State 1,ONCOGENIC_STK33_NOMO_DN,0.0,0.0,0.0,0.0,0.0284,0.0332
247,Tumor State 1,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.0186,0.0232
248,Tumor State 1,ONCOGENIC_STK33_SKM_DN,0.0,0.0,0.0,0.0,0.004,0.0054
249,Tumor State 1,ONCOGENIC_STK33_SKM_UP,0.0,0.0,0.0,0.0001,0.121,0.1345
251,Tumor State 1,ONCOGENIC_TBK1.DF_DN,0.0453,0.0412,0.8021,0.511,0.4368,0.4479
252,Tumor State 1,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.004,0.0053
253,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.3651,0.3604
254,Tumor State 1,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.184,0.1847
255,Tumor State 1,ONCOGENIC_TGFB_UP.V1_DN,0.0,0.0,0.0,0.0,0.2089,0.2339
256,Tumor State 1,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.0515,0.0607
257,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.1043,0.1111
258,Tumor State 1,ONCOGENIC_VEGF_A_UP.V1_UP,0.0,0.0,0.0,0.0,0.0258,0.0298
259,Tumor State 1,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.0043,0.006
260,Tumor State 1,ONCOGENIC_WNT_UP.V1_UP,0.0,0.0,0.0,0.0,0.2453,0.271
261,Tumor State 1,ONCOGENIC_YAP1_DN,0.0,0.0,0.0,0.0,0.4732,0.4656
262,Tumor State 1,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.0373,0.048
1,Tumor State 2,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.1875,0.1985
2,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.2295,0.2411
3,Tumor State 2,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.101,0.1305
4,Tumor State 2,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.2295,0.2369
5,Tumor State 2,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.2295,0.2369
6,Tumor State 2,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.2295,0.2369
7,Tumor State 2,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.5443,0.5208
8,Tumor State 2,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0,0.0,0.0,0.0,0.2295,0.2369
9,Tumor State 2,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.2295,0.2369
10,Tumor State 2,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.2295,0.2411
11,Tumor State 2,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2295,0.2369
13,Tumor State 2,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.2689,0.2868
15,Tumor State 2,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2295,0.2411
16,Tumor State 2,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.4618,0.4751
17,Tumor State 2,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.3745,0.3792
18,Tumor State 2,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.4618,0.4751
19,Tumor State 2,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.2295,0.2369
20,Tumor State 2,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0,0.0,0.0,0.0,0.101,0.1013
22,Tumor State 2,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.101,0.1013
23,Tumor State 2,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.2738,0.3108
24,Tumor State 2,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.2738,0.3108
25,Tumor State 2,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.2689,0.2868
26,Tumor State 2,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.0803,0.0884
27,Tumor State 2,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.2326,0.2481
28,Tumor State 2,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.0585,0.0631
29,Tumor State 2,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.2326,0.2445
30,Tumor State 2,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.1462,0.1681
32,Tumor State 2,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.0993,0.1094
33,Tumor State 2,HALLMARK_BILE_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.3,0.3079
34,Tumor State 2,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.0585,0.0631
35,Tumor State 2,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.0714,0.0818
36,Tumor State 2,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.0585,0.0631
37,Tumor State 2,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.1932,0.2065
38,Tumor State 2,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.4815,0.4809
39,Tumor State 2,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.1772,0.1809
40,Tumor State 2,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0018,0.0048,0.0001,0.0003,0.3447,0.3721
41,Tumor State 2,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0,0.0,0.0,0.0,0.4767,0.4646
42,Tumor State 2,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.1212,0.1298
43,Tumor State 2,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.4815,0.4625
44,Tumor State 2,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.0592,0.0656
46,Tumor State 2,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.0585,0.0636
47,Tumor State 2,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.0585,0.0631
48,Tumor State 2,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.1095,0.1159
49,Tumor State 2,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.1329,0.1475
50,Tumor State 2,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.1772,0.1908
52,Tumor State 2,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.0681,0.0776
53,Tumor State 2,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.3614,0.3785
54,Tumor State 2,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.0681,0.0716
55,Tumor State 2,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.2105,0.2097
56,Tumor State 2,HALLMARK_MYC_TARGETS_V2,0.0335,0.0371,0.048,0.0519,0.4815,0.4788
57,Tumor State 2,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.1329,0.1437
58,Tumor State 2,HALLMARK_NOTCH_SIGNALING,0.0,0.0,0.0,0.0,0.1329,0.1524
59,Tumor State 2,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.1462,0.1595
60,Tumor State 2,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.0714,0.0837
62,Tumor State 2,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.2598,0.2538
63,Tumor State 2,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.0803,0.0901
64,Tumor State 2,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.0592,0.0656
65,Tumor State 2,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.0681,0.0776
66,Tumor State 2,HALLMARK_SPERMATOGENESIS,0.0009,0.0008,0.0111,0.0118,0.4767,0.4726
67,Tumor State 2,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.0585,0.0631
68,Tumor State 2,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.0993,0.1106
69,Tumor State 2,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.0714,0.08
70,Tumor State 2,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.1212,0.1298
71,Tumor State 2,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.1329,0.1509
72,Tumor State 2,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0,0.0,0.0,0.0,0.3221,0.3446
73,Tumor State 2,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.3,0.3008
74,Tumor State 2,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0,0.0,0.1772,0.1976
75,Tumor State 2,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.1462,0.1715
77,Tumor State 2,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.1772,0.1983
78,Tumor State 2,ONCOGENIC_ALK_DN.V1_DN,0.0009,0.0006,0.0099,0.0064,0.4767,0.4788
79,Tumor State 2,ONCOGENIC_ALK_DN.V1_UP,0.0,0.0,0.0,0.0,0.3614,0.37
80,Tumor State 2,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.1663,0.1889
82,Tumor State 2,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.0927,0.1077
83,Tumor State 2,ONCOGENIC_ATF2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2326,0.2463
84,Tumor State 2,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0,0.1212,0.1367
85,Tumor State 2,ONCOGENIC_ATM_DN.V1_UP,0.0,0.0,0.0,0.0,0.3447,0.3619
86,Tumor State 2,ONCOGENIC_BCAT.100_UP.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.2993
87,Tumor State 2,ONCOGENIC_BCAT.100_UP.V1_UP,0.013,0.0149,0.007,0.0085,0.2728,0.2987
88,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0,0.0,0.0,0.0,0.1663,0.1715
89,Tumor State 2,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0,0.0,0.0,0.0,0.4815,0.483
90,Tumor State 2,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0001,0.0,0.0,0.4767,0.4625
92,Tumor State 2,ONCOGENIC_BMI1_DN.V1_DN,0.0,0.0,0.0,0.0,0.2105,0.2128
93,Tumor State 2,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.0927,0.1066
94,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.2598,0.2538
95,Tumor State 2,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.0714,0.0837
96,Tumor State 2,ONCOGENIC_BRCA1_DN.V1_DN,0.0,0.0,0.0,0.0,0.1329,0.1524
98,Tumor State 2,ONCOGENIC_CAHOY_ASTROCYTIC,0.0001,0.0001,0.0,0.0,0.3447,0.3446
99,Tumor State 2,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.0585,0.0631
100,Tumor State 2,ONCOGENIC_CAHOY_NEURONAL,0.0,0.0,0.0,0.0,0.4086,0.4022
101,Tumor State 2,ONCOGENIC_CAHOY_OLIGODENDROCUTIC,0.0,0.0,0.0,0.0,0.2326,0.2339
102,Tumor State 2,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.1095,0.1197
103,Tumor State 2,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.0714,0.0818
104,Tumor State 2,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0,0.0,0.0927,0.1058
105,Tumor State 2,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
106,Tumor State 2,ONCOGENIC_CRX_DN.V1_UP,0.0,0.0,0.0,0.0,0.1932,0.2128
107,Tumor State 2,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.2598,0.25
108,Tumor State 2,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0007,0.0008,0.0002,0.0002,0.3221,0.3234
109,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.2788
110,Tumor State 2,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0001,0.0001,0.0,0.0,0.2728,0.291
111,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.1932,0.1992
112,Tumor State 2,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.4327,0.4346
113,Tumor State 2,ONCOGENIC_CTIP_DN.V1_DN,0.0,0.0,0.0,0.0,0.1329,0.1491
114,Tumor State 2,ONCOGENIC_CTIP_DN.V1_UP,0.0,0.0,0.0,0.0,0.2105,0.2173
115,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0051,0.0055,0.0103,0.0113,0.4815,0.4788
116,Tumor State 2,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.1212,0.1437
117,Tumor State 2,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1462,0.1613
118,Tumor State 2,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1212,0.1336
120,Tumor State 2,ONCOGENIC_DCA_UP.V1_UP,0.0007,0.0008,0.0062,0.0064,0.4327,0.4367
121,Tumor State 2,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
123,Tumor State 2,ONCOGENIC_E2F3_UP.V1_DN,0.0,0.0,0.0,0.0,0.0592,0.0684
124,Tumor State 2,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0,0.0,0.0,0.0676,0.0717
125,Tumor State 2,ONCOGENIC_EGFR_UP.V1_DN,0.0301,0.0173,0.0279,0.0145,0.3614,0.3721
126,Tumor State 2,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.0592,0.0656
127,Tumor State 2,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0,0.0,0.0676,0.0741
129,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3614,0.3785
130,Tumor State 2,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.1932,0.2211
131,Tumor State 2,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0001,0.0001,0.0,0.0,0.4327,0.4185
134,Tumor State 2,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1932,0.1992
135,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
136,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.3781,0.3954
137,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0001,0.0001,0.3447,0.3446
138,Tumor State 2,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1095,0.1244
139,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.3447,0.3679
140,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0671,0.0571,0.0292,0.0215,0.4562,0.4246
141,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.3,0.3194
142,Tumor State 2,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1772,0.2023
143,Tumor State 2,ONCOGENIC_GLI1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1772,0.1889
144,Tumor State 2,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1462,0.1558
145,Tumor State 2,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.1095,0.1236
146,Tumor State 2,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.0676,0.0698
147,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.2598,0.2729
148,Tumor State 2,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.0585,0.0631
149,Tumor State 2,ONCOGENIC_IL15_UP.V1_DN,0.0,0.0,0.0,0.0,0.4562,0.4367
150,Tumor State 2,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.3614,0.37
151,Tumor State 2,ONCOGENIC_IL21_UP.V1_DN,0.0,0.0,0.0,0.0,0.4327,0.4388
152,Tumor State 2,ONCOGENIC_IL21_UP.V1_UP,0.0,0.0,0.0,0.0,0.3781,0.3954
153,Tumor State 2,ONCOGENIC_IL2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3221,0.3194
156,Tumor State 2,ONCOGENIC_JAK2_DN.V1_UP,0.0037,0.0031,0.0019,0.0016,0.4815,0.4767
158,Tumor State 2,ONCOGENIC_JNK_DN.V1_UP,0.0001,0.0002,0.0,0.0001,0.1932,0.2173
159,Tumor State 2,ONCOGENIC_KRAS.300_UP.V1_DN,0.0,0.0,0.0,0.0,0.4562,0.4562
161,Tumor State 2,ONCOGENIC_KRAS.50_UP.V1_DN,0.407,0.3455,0.007,0.0049,0.4767,0.4583
162,Tumor State 2,ONCOGENIC_KRAS.50_UP.V1_UP,0.1164,0.1093,0.0133,0.0102,0.4562,0.4583
163,Tumor State 2,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0003,0.0003,0.0428,0.0367,0.3447,0.3509
164,Tumor State 2,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0075,0.0072,0.0089,0.0093,0.1932,0.2043
165,Tumor State 2,ONCOGENIC_KRAS.600_UP.V1_DN,0.0,0.0,0.0,0.0,0.4815,0.4767
166,Tumor State 2,ONCOGENIC_KRAS.600_UP.V1_UP,0.0,0.0,0.0,0.0,0.4562,0.4388
167,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.0681,0.0735
168,Tumor State 2,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.007,0.0063,0.4398,0.4342,0.3614,0.3933
169,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0,0.0,0.0,0.0,0.0803,0.0884
170,Tumor State 2,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0511,0.0475,0.0408,0.0346,0.3614,0.3631
171,Tumor State 2,ONCOGENIC_KRAS.DF.V1_DN,0.0,0.0,0.0,0.0,0.1932,0.2097
172,Tumor State 2,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.1663,0.1854
173,Tumor State 2,ONCOGENIC_KRAS.KIDNEY_UP.V1_DN,0.0069,0.0086,0.0172,0.0204,0.3,0.3079
174,Tumor State 2,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0,0.0,0.0,0.0,0.3,0.309
175,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0,0.0,0.0159,0.0191,0.1329,0.1437
176,Tumor State 2,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_UP,0.0,0.0,0.0,0.0,0.1095,0.1211
177,Tumor State 2,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.3221,0.3234
178,Tumor State 2,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0,0.0,0.0033,0.0035,0.4086,0.4374
179,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.3781,0.3679
180,Tumor State 2,ONCOGENIC_KRAS.PROSTATE_UP.V1_UP,0.0267,0.0364,0.0265,0.0344,0.3447,0.355
182,Tumor State 2,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.2105,0.2463
183,Tumor State 2,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4086,0.3954
184,Tumor State 2,ONCOGENIC_LTE2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2728,0.291
185,Tumor State 2,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0008,0.0006,0.3614,0.3679
186,Tumor State 2,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.0993,0.1159
187,Tumor State 2,ONCOGENIC_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.291
188,Tumor State 2,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.0592,0.0684
189,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0001,0.0,0.0,0.2728,0.2987
190,Tumor State 2,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.3221,0.3194
192,Tumor State 2,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.3614,0.366
193,Tumor State 2,ONCOGENIC_MYC_UP.V1_DN,0.0008,0.001,0.0012,0.0014,0.3781,0.3954
194,Tumor State 2,ONCOGENIC_MYC_UP.V1_UP,0.0,0.0,0.0,0.0,0.0993,0.1109
195,Tumor State 2,ONCOGENIC_NFE2L2.V2,0.0,0.0,0.0,0.0,0.1212,0.1367
196,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_DN,0.0018,0.002,0.0,0.0,0.3781,0.3954
197,Tumor State 2,ONCOGENIC_NOTCH_DN.V1_UP,0.0,0.0,0.0,0.0,0.2326,0.25
198,Tumor State 2,ONCOGENIC_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.0714,0.0818
199,Tumor State 2,ONCOGENIC_NRL_DN.V1_UP,0.0003,0.0003,0.0002,0.0003,0.3221,0.3426
200,Tumor State 2,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.1772,0.2043
201,Tumor State 2,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.2105,0.2347
202,Tumor State 2,ONCOGENIC_P53_DN.V2_DN,0.024,0.025,0.0063,0.0074,0.4815,0.4809
204,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0828,0.0648,0.0092,0.0064,0.4815,0.4809
205,Tumor State 2,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.1663,0.1829
206,Tumor State 2,ONCOGENIC_PDGF_UP.V1_DN,0.0002,0.0001,0.0,0.0,0.3781,0.3976
207,Tumor State 2,ONCOGENIC_PDGF_UP.V1_UP,0.0015,0.0016,0.0008,0.0009,0.1462,0.1558
208,Tumor State 2,ONCOGENIC_PIGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.1462,0.1664
209,Tumor State 2,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.0681,0.0776
210,Tumor State 2,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
211,Tumor State 2,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0001,0.1772,0.1854
212,Tumor State 2,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.0,0.0,0.0,0.0,0.1095,0.1195
213,Tumor State 2,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0376,0.0398,0.094,0.1017,0.2728,0.2768
214,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0057,0.0056,0.0025,0.0032,0.4562,0.4625
215,Tumor State 2,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0,0.0,0.0,0.0,0.0927,0.1036
216,Tumor State 2,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0,0.0,0.0,0.0,0.2105,0.2339
218,Tumor State 2,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0,0.0,0.0,0.0,0.0993,0.1089
220,Tumor State 2,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.4562,0.4562
221,Tumor State 2,ONCOGENIC_PTEN_DN.V1_UP,0.0,0.0,0.0,0.0,0.1663,0.1837
223,Tumor State 2,ONCOGENIC_PTEN_DN.V2_UP,0.0254,0.0349,0.0063,0.01,0.1772,0.1976
224,Tumor State 2,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.3614,0.3872
225,Tumor State 2,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.1772,0.1893
226,Tumor State 2,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.2105,0.2283
227,Tumor State 2,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.0,0.0,0.0043,0.0047,0.3,0.3194
228,Tumor State 2,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.2834
229,Tumor State 2,ONCOGENIC_RB_DN.V1_UP,0.0453,0.0543,0.0859,0.1025,0.1462,0.1648
230,Tumor State 2,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.0681,0.0755
231,Tumor State 2,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.2326,0.2301
232,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
233,Tumor State 2,ONCOGENIC_RB_P130_DN.V1_UP,0.0,0.0,0.0,0.0,0.0681,0.0776
234,Tumor State 2,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.3028
235,Tumor State 2,ONCOGENIC_RELA_DN.V1_UP,0.0091,0.0101,0.0,0.0,0.1932,0.2061
237,Tumor State 2,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.0803,0.0957
238,Tumor State 2,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0211,0.0187,0.2733,0.2408,0.3614,0.366
239,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
240,Tumor State 2,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.0714,0.0776
241,Tumor State 2,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.1772,0.2043
242,Tumor State 2,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.0993,0.1073
243,Tumor State 2,ONCOGENIC_SRC_UP.V1_DN,0.0,0.0,0.0,0.0,0.3221,0.3194
244,Tumor State 2,ONCOGENIC_SRC_UP.V1_UP,0.0,0.0,0.0,0.0,0.0585,0.0653
245,Tumor State 2,ONCOGENIC_STK33_DN,0.0379,0.0278,0.0051,0.004,0.4815,0.4916
246,Tumor State 2,ONCOGENIC_STK33_NOMO_DN,0.0332,0.0305,0.1656,0.1632,0.4327,0.4346
247,Tumor State 2,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.0803,0.0919
248,Tumor State 2,ONCOGENIC_STK33_SKM_DN,0.0469,0.049,0.2618,0.2687,0.4767,0.4625
249,Tumor State 2,ONCOGENIC_STK33_SKM_UP,0.0,0.0,0.0,0.0,0.0993,0.1141
250,Tumor State 2,ONCOGENIC_STK33_UP,0.0,0.0,0.0,0.0,0.0993,0.1119
251,Tumor State 2,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.1095,0.1195
252,Tumor State 2,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.1329,0.1576
253,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
254,Tumor State 2,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.2598,0.291
255,Tumor State 2,ONCOGENIC_TGFB_UP.V1_DN,0.0,0.0,0.0,0.0,0.2728,0.2788
256,Tumor State 2,ONCOGENIC_TGFB_UP.V1_UP,0.0003,0.0003,0.0002,0.0003,0.2105,0.2211
257,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.0585,0.0631
258,Tumor State 2,ONCOGENIC_VEGF_A_UP.V1_UP,0.0,0.0,0.0,0.0,0.4086,0.4346
259,Tumor State 2,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.3781,0.4132
260,Tumor State 2,ONCOGENIC_WNT_UP.V1_UP,0.0,0.0,0.0,0.0,0.3447,0.3659
261,Tumor State 2,ONCOGENIC_YAP1_DN,0.0,0.0,0.0004,0.0003,0.4767,0.4583
262,Tumor State 2,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.1212,0.1367
1,Tumor State 4,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.4078,0.3784
2,Tumor State 4,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.3691,0.3555
3,Tumor State 4,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.4078,0.3784
4,Tumor State 4,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.3691,0.3555
5,Tumor State 4,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0,0.0,0.0,0.0,0.3691,0.3555
6,Tumor State 4,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0,0.0,0.0,0.3691,0.3555
7,Tumor State 4,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0,0.0,0.0,0.0,0.3691,0.3555
8,Tumor State 4,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0,0.0,0.0,0.0,0.4117,0.4468
9,Tumor State 4,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0,0.0,0.0,0.0,0.4078,0.3784
10,Tumor State 4,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0,0.0,0.0,0.3691,0.3555
11,Tumor State 4,REACTOME_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.3691,0.3555
13,Tumor State 4,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0,0.0,0.0,0.4117,0.419
15,Tumor State 4,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.3691,0.3592
16,Tumor State 4,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0001,0.4117,0.4581
17,Tumor State 4,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0,0.0,0.0,0.0,0.3691,0.3555
18,Tumor State 4,ZHANG_INTERFERON_RESPONSE,0.0,0.0,0.0,0.0,0.3691,0.3555
19,Tumor State 4,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0,0.0,0.0,0.5003,0.4859
20,Tumor State 4,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0009,0.0018,0.0001,0.0003,0.4117,0.4581
21,Tumor State 4,PAM50,0.0026,0.0045,0.3896,0.3442,0.4117,0.4859
22,Tumor State 4,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.3691,0.3555
23,Tumor State 4,WU_ET_AL_HER2E_SC,0.0,0.0,0.0,0.0,0.4078,0.4062
24,Tumor State 4,WU_ET_AL_LUMA_SC,0.0,0.0,0.0,0.0,0.5003,0.4859
25,Tumor State 4,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.4117,0.4859
26,Tumor State 4,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.4426,0.4298
27,Tumor State 4,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.3122,0.3267
28,Tumor State 4,HALLMARK_ANDROGEN_RESPONSE,0.0,0.0,0.0,0.0,0.4426,0.4298
29,Tumor State 4,HALLMARK_ANGIOGENESIS,0.0,0.0,0.0,0.0,0.4426,0.4298
30,Tumor State 4,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.319,0.3515
32,Tumor State 4,HALLMARK_APOPTOSIS,0.0,0.0,0.0,0.0,0.319,0.3556
34,Tumor State 4,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0,0.0,0.0,0.0,0.4118,0.4053
35,Tumor State 4,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0,0.3407,0.4095
36,Tumor State 4,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.319,0.339
37,Tumor State 4,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.4426,0.4298
38,Tumor State 4,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.3407,0.4052
39,Tumor State 4,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.3122,0.3267
40,Tumor State 4,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0,0.0,0.0,0.0,0.319,0.3808
41,Tumor State 4,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0096,0.0652,0.0011,0.0123,0.3407,0.4052
42,Tumor State 4,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.4118,0.4095
43,Tumor State 4,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.3407,0.4052
44,Tumor State 4,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.3407,0.3881
46,Tumor State 4,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.319,0.3556
47,Tumor State 4,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.319,0.3556
48,Tumor State 4,HALLMARK_IL2_STAT5_SIGNALING,0.0,0.0,0.0,0.0,0.3122,0.3267
49,Tumor State 4,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.1911,0.2796
50,Tumor State 4,HALLMARK_INFLAMMATORY_RESPONSE,0.0,0.0,0.0,0.0,0.1911,0.2796
51,Tumor State 4,HALLMARK_KRAS_SIGNALING_DN,0.0,0.0,0.0,0.0001,0.4426,0.4298
52,Tumor State 4,HALLMARK_KRAS_SIGNALING_UP,0.0,0.0,0.0,0.0,0.3122,0.3267
53,Tumor State 4,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.319,0.3556
54,Tumor State 4,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.4118,0.4095
55,Tumor State 4,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.4426,0.4298
56,Tumor State 4,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.4118,0.4052
57,Tumor State 4,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.319,0.3515
58,Tumor State 4,HALLMARK_NOTCH_SIGNALING,0.0,0.0,0.0,0.0,0.3122,0.3267
59,Tumor State 4,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.4426,0.4298
60,Tumor State 4,HALLMARK_P53_PATHWAY,0.0,0.0,0.0,0.0,0.319,0.339
61,Tumor State 4,HALLMARK_PANCREAS_BETA_CELLS,0.0001,0.0011,0.0045,0.0099,0.4118,0.4298
62,Tumor State 4,HALLMARK_PEROXISOME,0.0,0.0,0.0,0.0,0.319,0.3672
63,Tumor State 4,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.4118,0.4053
64,Tumor State 4,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.3407,0.3838
65,Tumor State 4,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.4118,0.4053
66,Tumor State 4,HALLMARK_SPERMATOGENESIS,0.0517,0.0382,0.0916,0.0641,0.319,0.3753
67,Tumor State 4,HALLMARK_TGF_BETA_SIGNALING,0.0,0.0,0.0,0.0,0.319,0.339
68,Tumor State 4,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0,0.0,0.0,0.0,0.319,0.339
69,Tumor State 4,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.4118,0.4095
70,Tumor State 4,HALLMARK_UV_RESPONSE_DN,0.0,0.0,0.0,0.0,0.3407,0.3838
71,Tumor State 4,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
72,Tumor State 4,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.1545,0.2267,0.0293,0.0549,0.3122,0.3252
73,Tumor State 4,HALLMARK_XENOBIOTIC_METABOLISM,0.0,0.0,0.0,0.0,0.4118,0.4095
74,Tumor State 4,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0,0.0,0.0,0.1911,0.2796
75,Tumor State 4,ONCOGENIC_AKT_UP.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.4053
76,Tumor State 4,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0144,0.0291,0.0264,0.0605,0.3122,0.3252
77,Tumor State 4,ONCOGENIC_AKT_UP_MTOR_DN.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.4053
78,Tumor State 4,ONCOGENIC_ALK_DN.V1_DN,0.0003,0.0007,0.0021,0.0056,0.319,0.3886
79,Tumor State 4,ONCOGENIC_ALK_DN.V1_UP,0.0052,0.0098,0.0003,0.0009,0.1911,0.2796
80,Tumor State 4,ONCOGENIC_ATF2_S_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3515
81,Tumor State 4,ONCOGENIC_ATF2_S_UP.V1_UP,0.0024,0.0011,0.0009,0.0004,0.4426,0.4298
82,Tumor State 4,ONCOGENIC_ATF2_UP.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.3881
84,Tumor State 4,ONCOGENIC_ATM_DN.V1_DN,0.0,0.0,0.0,0.0001,0.1911,0.2796
86,Tumor State 4,ONCOGENIC_BCAT.100_UP.V1_DN,0.0466,0.0341,0.672,0.3061,0.3407,0.4052
87,Tumor State 4,ONCOGENIC_BCAT.100_UP.V1_UP,0.0017,0.0047,0.0003,0.0016,0.3122,0.3267
88,Tumor State 4,ONCOGENIC_BCAT_BILD_ET_AL_DN,0.0,0.0,0.0,0.0,0.3407,0.3723
89,Tumor State 4,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0,0.0,0.0,0.0,0.319,0.3515
90,Tumor State 4,ONCOGENIC_BCAT_GDS748_DN,0.0,0.0,0.0,0.0,0.4118,0.4095
91,Tumor State 4,ONCOGENIC_BCAT_GDS748_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
92,Tumor State 4,ONCOGENIC_BMI1_DN.V1_DN,0.0,0.0,0.0,0.0,0.4426,0.4298
93,Tumor State 4,ONCOGENIC_BMI1_DN.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
94,Tumor State 4,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.4118,0.4052
95,Tumor State 4,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
96,Tumor State 4,ONCOGENIC_BRCA1_DN.V1_DN,0.0004,0.0004,0.0006,0.0006,0.4426,0.4298
97,Tumor State 4,ONCOGENIC_BRCA1_DN.V1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
98,Tumor State 4,ONCOGENIC_CAHOY_ASTROCYTIC,0.052,0.0429,0.1069,0.1995,0.4426,0.4298
99,Tumor State 4,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.4426,0.4298
100,Tumor State 4,ONCOGENIC_CAHOY_NEURONAL,0.0,0.0,0.0009,0.0015,0.4426,0.4298
102,Tumor State 4,ONCOGENIC_CAMP_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.339
103,Tumor State 4,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.3881
104,Tumor State 4,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0,0.0,0.319,0.3724
105,Tumor State 4,ONCOGENIC_CRX_DN.V1_DN,0.0,0.0,0.0,0.0,0.1911,0.2796
107,Tumor State 4,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0,0.0,0.0001,0.0001,0.3407,0.4141
109,Tumor State 4,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.001,0.0009,0.0029,0.0024,0.3407,0.3881
110,Tumor State 4,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
111,Tumor State 4,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3681
112,Tumor State 4,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3938
113,Tumor State 4,ONCOGENIC_CTIP_DN.V1_DN,0.0148,0.0153,0.2167,0.1376,0.319,0.385
115,Tumor State 4,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0,0.0,0.0,0.0,0.3122,0.3267
116,Tumor State 4,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3556
117,Tumor State 4,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3566
118,Tumor State 4,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3938
119,Tumor State 4,ONCOGENIC_DCA_UP.V1_DN,0.0145,0.0178,0.0237,0.0288,0.3122,0.2837
121,Tumor State 4,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3556
122,Tumor State 4,ONCOGENIC_E2F1_UP.V1_UP,0.0001,0.0013,0.0029,0.0086,0.4118,0.4298
123,Tumor State 4,ONCOGENIC_E2F3_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3938
124,Tumor State 4,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
125,Tumor State 4,ONCOGENIC_EGFR_UP.V1_DN,0.0,0.0,0.0003,0.0003,0.4426,0.4298
126,Tumor State 4,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
127,Tumor State 4,ONCOGENIC_EIF4E_DN,0.0,0.0,0.0,0.0,0.319,0.3556
128,Tumor State 4,ONCOGENIC_EIF4E_UP,0.0,0.0,0.0,0.0,0.319,0.3566
129,Tumor State 4,ONCOGENIC_ERBB2_UP.V1_DN,0.0,0.0,0.0,0.0,0.4118,0.4095
130,Tumor State 4,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
131,Tumor State 4,ONCOGENIC_ESC_J1_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3515
133,Tumor State 4,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0,0.0001,0.0001,0.0001,0.1911,0.2796
134,Tumor State 4,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
135,Tumor State 4,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3515
136,Tumor State 4,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.012,0.0237,0.0141,0.0252,0.4426,0.4298
137,Tumor State 4,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.1911,0.2796
138,Tumor State 4,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
139,Tumor State 4,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.4426,0.4298
140,Tumor State 4,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
141,Tumor State 4,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.319,0.4052
142,Tumor State 4,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
143,Tumor State 4,ONCOGENIC_GLI1_UP.V1_DN,0.0038,0.0056,0.0005,0.0006,0.1911,0.2796
144,Tumor State 4,ONCOGENIC_GLI1_UP.V1_UP,0.0,0.0,0.0,0.0,0.3407,0.4053
145,Tumor State 4,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0,0.0,0.2897,0.3252
146,Tumor State 4,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0,0.0,0.4426,0.4298
147,Tumor State 4,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.1911,0.2796
148,Tumor State 4,ONCOGENIC_HOXA9_DN.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3556
150,Tumor State 4,ONCOGENIC_IL15_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.4052
151,Tumor State 4,ONCOGENIC_IL21_UP.V1_DN,0.0003,0.0045,0.0002,0.0024,0.4426,0.4298
154,Tumor State 4,ONCOGENIC_IL2_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3515
155,Tumor State 4,ONCOGENIC_JAK2_DN.V1_DN,0.0516,0.0365,0.006,0.0051,0.4426,0.4298
156,Tumor State 4,ONCOGENIC_JAK2_DN.V1_UP,0.0002,0.0005,0.0,0.0002,0.3407,0.4095
158,Tumor State 4,ONCOGENIC_JNK_DN.V1_UP,0.0002,0.0011,0.0003,0.0014,0.4118,0.4298
160,Tumor State 4,ONCOGENIC_KRAS.300_UP.V1_UP,0.0037,0.0093,0.019,0.0723,0.4426,0.4298
161,Tumor State 4,ONCOGENIC_KRAS.50_UP.V1_DN,0.0026,0.0015,0.2991,0.2076,0.4118,0.4141
162,Tumor State 4,ONCOGENIC_KRAS.50_UP.V1_UP,0.0369,0.0373,0.6955,0.3787,0.4426,0.4298
163,Tumor State 4,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_DN,0.0007,0.0005,0.0066,0.0022,0.319,0.3753
164,Tumor State 4,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0255,0.0318,0.0297,0.0378,0.3407,0.4095
166,Tumor State 4,ONCOGENIC_KRAS.600_UP.V1_UP,0.0004,0.0045,0.0022,0.0151,0.4118,0.4298
167,Tumor State 4,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.4426,0.4298
168,Tumor State 4,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0001,0.0001,0.0066,0.0077,0.4118,0.4298
169,Tumor State 4,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.052,0.0175,0.1228,0.0376,0.319,0.3753
172,Tumor State 4,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0,0.0,0.0,0.319,0.339
175,Tumor State 4,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0038,0.0013,0.0572,0.0301,0.3407,0.4141
178,Tumor State 4,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0841,0.0467,0.5488,0.3287,0.3407,0.4052
181,Tumor State 4,ONCOGENIC_LEF1_UP.V1_DN,0.0088,0.032,0.0271,0.0665,0.4426,0.4298
182,Tumor State 4,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.2897,0.2924
183,Tumor State 4,ONCOGENIC_LTE2_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3556
184,Tumor State 4,ONCOGENIC_LTE2_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3672
185,Tumor State 4,ONCOGENIC_MEK_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3556
186,Tumor State 4,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
187,Tumor State 4,ONCOGENIC_MEL18_DN.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.3838
188,Tumor State 4,ONCOGENIC_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
189,Tumor State 4,ONCOGENIC_MTOR_UP.N4.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3556
190,Tumor State 4,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3556
191,Tumor State 4,ONCOGENIC_MTOR_UP.V1_DN,0.0,0.0,0.0,0.0,0.2897,0.3252
192,Tumor State 4,ONCOGENIC_MTOR_UP.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
193,Tumor State 4,ONCOGENIC_MYC_UP.V1_DN,0.0469,0.0244,0.2661,0.1453,0.319,0.3222
194,Tumor State 4,ONCOGENIC_MYC_UP.V1_UP,0.1032,0.0692,0.0097,0.0113,0.3407,0.4141
196,Tumor State 4,ONCOGENIC_NOTCH_DN.V1_DN,0.0433,0.0655,0.0811,0.1171,0.319,0.3534
197,Tumor State 4,ONCOGENIC_NOTCH_DN.V1_UP,0.0108,0.0221,0.0151,0.0178,0.3407,0.4141
198,Tumor State 4,ONCOGENIC_NRL_DN.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.4141
200,Tumor State 4,ONCOGENIC_P53_DN.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3556
201,Tumor State 4,ONCOGENIC_P53_DN.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3515
202,Tumor State 4,ONCOGENIC_P53_DN.V2_DN,0.0012,0.0014,0.0058,0.0052,0.4426,0.4298
203,Tumor State 4,ONCOGENIC_P53_DN.V2_UP,0.0,0.0,0.0,0.0,0.319,0.3938
204,Tumor State 4,ONCOGENIC_PDGF_ERK_DN.V1_DN,0.0,0.0,0.0,0.0,0.319,0.339
205,Tumor State 4,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.3122,0.3267
206,Tumor State 4,ONCOGENIC_PDGF_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3672
207,Tumor State 4,ONCOGENIC_PDGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3556
209,Tumor State 4,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0,0.0,0.0,0.4118,0.4053
210,Tumor State 4,ONCOGENIC_PKCA_DN.V1_DN,0.0,0.0,0.0,0.0,0.1911,0.2796
211,Tumor State 4,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
212,Tumor State 4,ONCOGENIC_PRC1_BMI_UP.V1_DN,0.0003,0.0008,0.0001,0.0006,0.4118,0.4141
215,Tumor State 4,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0003,0.0014,0.0005,0.0021,0.319,0.3845
216,Tumor State 4,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0681,0.0369,0.0017,0.0009,0.4118,0.4298
217,Tumor State 4,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0009,0.0022,0.001,0.0016,0.2897,0.2837
218,Tumor State 4,ONCOGENIC_PRC2_SUZ12_UP.V1_DN,0.0001,0.0001,0.0,0.0001,0.4426,0.4298
219,Tumor State 4,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.007,0.007,0.0373,0.0439,0.4426,0.4298
220,Tumor State 4,ONCOGENIC_PTEN_DN.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.4298
221,Tumor State 4,ONCOGENIC_PTEN_DN.V1_UP,0.0004,0.0002,0.0035,0.0031,0.4118,0.4298
224,Tumor State 4,ONCOGENIC_RAF_UP.V1_DN,0.2306,0.0865,0.0423,0.1073,0.319,0.385
225,Tumor State 4,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.1911,0.2796
226,Tumor State 4,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.339
228,Tumor State 4,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.4052
229,Tumor State 4,ONCOGENIC_RB_DN.V1_UP,0.0003,0.0005,0.0012,0.0022,0.3407,0.4047
230,Tumor State 4,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.3122,0.3267
231,Tumor State 4,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3938
232,Tumor State 4,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.3407,0.4052
233,Tumor State 4,ONCOGENIC_RB_P130_DN.V1_UP,0.0105,0.0084,0.009,0.0068,0.4426,0.4298
234,Tumor State 4,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0,0.0,0.4426,0.4298
235,Tumor State 4,ONCOGENIC_RELA_DN.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3896
236,Tumor State 4,ONCOGENIC_RPS14_DN.V1_DN,0.0001,0.0001,0.0,0.0,0.4426,0.4298
237,Tumor State 4,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.319,0.339
238,Tumor State 4,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0,0.0,0.0001,0.0001,0.4426,0.4298
239,Tumor State 4,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.3122,0.3267
240,Tumor State 4,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.3407,0.3838
241,Tumor State 4,ONCOGENIC_SNF5_DN.V1_DN,0.0,0.0,0.0,0.0,0.3122,0.3252
242,Tumor State 4,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.3122,0.3267
244,Tumor State 4,ONCOGENIC_SRC_UP.V1_UP,0.0001,0.0003,0.0,0.0001,0.4426,0.4298
246,Tumor State 4,ONCOGENIC_STK33_NOMO_DN,0.0012,0.0005,0.0073,0.0015,0.319,0.3222
247,Tumor State 4,ONCOGENIC_STK33_NOMO_UP,0.0,0.0,0.0,0.0,0.319,0.339
249,Tumor State 4,ONCOGENIC_STK33_SKM_UP,0.0,0.0,0.0,0.0,0.3122,0.3267
250,Tumor State 4,ONCOGENIC_STK33_UP,0.0,0.0,0.0,0.0,0.319,0.3556
251,Tumor State 4,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.4118,0.4095
252,Tumor State 4,ONCOGENIC_TBK1.DF_UP,0.0,0.0,0.0,0.0,0.319,0.339
253,Tumor State 4,ONCOGENIC_TBK1.DN.48HRS_DN,0.0,0.0,0.0,0.0,0.3407,0.3881
254,Tumor State 4,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.319,0.3556
255,Tumor State 4,ONCOGENIC_TGFB_UP.V1_DN,0.0034,0.0085,0.0092,0.0148,0.4426,0.4298
256,Tumor State 4,ONCOGENIC_TGFB_UP.V1_UP,0.0,0.0,0.0,0.0,0.3122,0.3267
257,Tumor State 4,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.339
258,Tumor State 4,ONCOGENIC_VEGF_A_UP.V1_UP,0.0,0.0,0.0,0.0,0.319,0.3838
259,Tumor State 4,ONCOGENIC_WNT_UP.V1_DN,0.0,0.0,0.0,0.0,0.319,0.3431
261,Tumor State 4,ONCOGENIC_YAP1_DN,0.0059,0.0075,0.0348,0.0428,0.3122,0.2924
262,Tumor State 4,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.4426,0.4298
1,Tumor State 5,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.0,0.0,0.0,0.0,0.1939,0.25
2,Tumor State 5,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.0,0.0,0.0,0.0,0.1313,0.1972
3,Tumor State 5,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.0,0.0,0.0,0.0,0.1313,0.1943
4,Tumor State 5,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.0,0.0,0.0,0.0,0.1313,0.1943
5,Tumor State 5,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.0385,0.0577,0.0204,0.1526,0.3759,0.4114
6,Tumor State 5,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.0,0.0001,0.0,0.0001,0.2256,0.3118
7,Tumor State 5,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.0445,0.0593,0.0073,0.0482,0.3058,0.3205
8,Tumor State 5,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.0001,0.0026,0.0001,0.0032,0.2256,0.2915
9,Tumor State 5,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.0012,0.0028,0.0016,0.0052,0.1939,0.2442
10,Tumor State 5,REACTOME_INTERFERON_GAMMA_SIGNALING,0.0,0.0002,0.0,0.0,0.1939,0.25
11,Tumor State 5,REACTOME_INTERFERON_SIGNALING,0.0,0.0001,0.0,0.0,0.2256,0.3118
13,Tumor State 5,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,0.0,0.0002,0.0,0.0001,0.1313,0.1943
15,Tumor State 5,WP_TYPE_II_INTERFERON_SIGNALING,0.0,0.0,0.0,0.0,0.2256,0.3118
16,Tumor State 5,WP_TYPE_III_INTERFERON_SIGNALING,0.0,0.0001,0.0003,0.0006,0.2256,0.2974
17,Tumor State 5,BROWNE_INTERFERON_RESPONSIVE_GENES,0.0012,0.0062,0.0004,0.0047,0.3759,0.4114
18,Tumor State 5,ZHANG_INTERFERON_RESPONSE,0.1308,0.0331,0.1876,0.0707,0.3058,0.3263
19,Tumor State 5,REACTOME_CYTOPROTECTION_BY_HMOX1,0.0,0.0003,0.0,0.0,0.1939,0.2442
20,Tumor State 5,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.0,0.0001,0.0008,0.0017,0.1939,0.2116
21,Tumor State 5,PAM50,0.0021,0.0037,0.0015,0.0043,0.1313,0.1943
22,Tumor State 5,WU_ET_AL_BASAL_SC,0.0,0.0,0.0,0.0,0.1313,0.1943
23,Tumor State 5,WU_ET_AL_HER2E_SC,0.0,0.0001,0.0,0.0,0.1939,0.2442
24,Tumor State 5,WU_ET_AL_LUMA_SC,0.0004,0.0015,0.0257,0.0487,0.3759,0.3723
25,Tumor State 5,WU_EL_AL_LUMB_SC,0.0,0.0,0.0,0.0,0.1939,0.2391
26,Tumor State 5,HALLMARK_ADIPOGENESIS,0.0,0.0,0.0,0.0,0.3492,0.3768
27,Tumor State 5,HALLMARK_ALLOGRAFT_REJECTION,0.0,0.0,0.0,0.0,0.1678,0.2231
30,Tumor State 5,HALLMARK_APICAL_JUNCTION,0.0,0.0,0.0,0.0,0.1448,0.1879
32,Tumor State 5,HALLMARK_APOPTOSIS,0.0003,0.0004,0.0002,0.0003,0.3973,0.3914
33,Tumor State 5,HALLMARK_BILE_ACID_METABOLISM,0.0002,0.0006,0.0001,0.0003,0.2126,0.2665
34,Tumor State 5,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.0013,0.0022,0.0022,0.0025,0.2666,0.3163
35,Tumor State 5,HALLMARK_COAGULATION,0.0,0.0,0.0,0.0001,0.1448,0.1894
36,Tumor State 5,HALLMARK_COMPLEMENT,0.0,0.0,0.0,0.0,0.1448,0.1879
37,Tumor State 5,HALLMARK_DNA_REPAIR,0.0,0.0,0.0,0.0,0.2666,0.3084
38,Tumor State 5,HALLMARK_E2F_TARGETS,0.0,0.0,0.0,0.0,0.1448,0.1965
39,Tumor State 5,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.0,0.0,0.0,0.0,0.1448,0.1879
40,Tumor State 5,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.0,0.0,0.0,0.0,0.1448,0.1879
41,Tumor State 5,HALLMARK_ESTROGEN_RESPONSE_LATE,0.0,0.0,0.0,0.0,0.1448,0.1894
42,Tumor State 5,HALLMARK_FATTY_ACID_METABOLISM,0.0,0.0,0.0,0.0,0.2666,0.3084
43,Tumor State 5,HALLMARK_G2M_CHECKPOINT,0.0,0.0,0.0,0.0,0.1448,0.1965
44,Tumor State 5,HALLMARK_GLYCOLYSIS,0.0,0.0,0.0,0.0,0.1448,0.1965
46,Tumor State 5,HALLMARK_HEME_METABOLISM,0.0,0.0,0.0,0.0,0.1448,0.1879
47,Tumor State 5,HALLMARK_HYPOXIA,0.0,0.0,0.0,0.0,0.2126,0.2665
48,Tumor State 5,HALLMARK_IL2_STAT5_SIGNALING,0.0089,0.0032,0.0009,0.0004,0.3973,0.3841
49,Tumor State 5,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.0,0.0,0.0,0.0,0.1448,0.1879
50,Tumor State 5,HALLMARK_INFLAMMATORY_RESPONSE,0.0102,0.0123,0.0002,0.0006,0.1448,0.1879
52,Tumor State 5,HALLMARK_KRAS_SIGNALING_UP,0.0083,0.0261,0.0112,0.0392,0.2126,0.2715
53,Tumor State 5,HALLMARK_MITOTIC_SPINDLE,0.0,0.0,0.0,0.0,0.1448,0.1965
54,Tumor State 5,HALLMARK_MTORC1_SIGNALING,0.0,0.0,0.0,0.0,0.1678,0.239
55,Tumor State 5,HALLMARK_MYC_TARGETS_V1,0.0,0.0,0.0,0.0,0.1448,0.1965
56,Tumor State 5,HALLMARK_MYC_TARGETS_V2,0.0,0.0,0.0,0.0,0.1678,0.2413
57,Tumor State 5,HALLMARK_MYOGENESIS,0.0,0.0,0.0,0.0,0.1448,0.1907
59,Tumor State 5,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.0,0.0,0.0,0.0,0.2666,0.3084
60,Tumor State 5,HALLMARK_P53_PATHWAY,0.001,0.0059,0.0004,0.0027,0.1678,0.2413
62,Tumor State 5,HALLMARK_PEROXISOME,0.0004,0.0059,0.0004,0.0044,0.2666,0.3184
63,Tumor State 5,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.0,0.0,0.0,0.0,0.2126,0.2791
64,Tumor State 5,HALLMARK_PROTEIN_SECRETION,0.0,0.0,0.0,0.0,0.2126,0.2741
65,Tumor State 5,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.0,0.0,0.0,0.0,0.2126,0.277
66,Tumor State 5,HALLMARK_SPERMATOGENESIS,0.0002,0.0006,0.0,0.0001,0.1448,0.1879
68,Tumor State 5,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.0003,0.0024,0.0202,0.072,0.3973,0.3914
69,Tumor State 5,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.0,0.0,0.0,0.0,0.1448,0.1965
71,Tumor State 5,HALLMARK_UV_RESPONSE_UP,0.0,0.0,0.0,0.0,0.2126,0.277
72,Tumor State 5,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.0005,0.0035,0.0006,0.0046,0.1678,0.2199
74,Tumor State 5,ONCOGENIC_AKT_UP.V1_DN,0.0,0.0001,0.0,0.0,0.1448,0.1907
75,Tumor State 5,ONCOGENIC_AKT_UP.V1_UP,0.0351,0.0919,0.0934,0.2161,0.3492,0.3808
76,Tumor State 5,ONCOGENIC_AKT_UP_MTOR_DN.V1_DN,0.0322,0.0441,0.0664,0.0804,0.4426,0.4298
78,Tumor State 5,ONCOGENIC_ALK_DN.V1_DN,0.0228,0.02,0.0611,0.0643,0.3973,0.3808
79,Tumor State 5,ONCOGENIC_ALK_DN.V1_UP,0.0003,0.0009,0.0004,0.0011,0.3492,0.374
81,Tumor State 5,ONCOGENIC_ATF2_S_UP.V1_UP,0.0249,0.0381,0.0324,0.0479,0.3492,0.3808
83,Tumor State 5,ONCOGENIC_ATF2_UP.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2276
85,Tumor State 5,ONCOGENIC_ATM_DN.V1_UP,0.0004,0.0009,0.0009,0.0017,0.2126,0.2791
89,Tumor State 5,ONCOGENIC_BCAT_BILD_ET_AL_UP,0.0005,0.0007,0.0038,0.0073,0.2126,0.2625
90,Tumor State 5,ONCOGENIC_BCAT_GDS748_DN,0.1028,0.1746,0.0298,0.052,0.3492,0.3537
92,Tumor State 5,ONCOGENIC_BMI1_DN.V1_DN,0.0452,0.1252,0.061,0.1301,0.4426,0.4298
93,Tumor State 5,ONCOGENIC_BMI1_DN.V1_UP,0.0127,0.0129,0.0065,0.01,0.2666,0.3196
94,Tumor State 5,ONCOGENIC_BMI1_DN_MEL18_DN.V1_DN,0.0002,0.0041,0.0007,0.0032,0.3973,0.3914
95,Tumor State 5,ONCOGENIC_BMI1_DN_MEL18_DN.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2117
97,Tumor State 5,ONCOGENIC_BRCA1_DN.V1_UP,0.0408,0.0702,0.1514,0.1608,0.4426,0.4298
98,Tumor State 5,ONCOGENIC_CAHOY_ASTROCYTIC,0.0023,0.005,0.002,0.0044,0.2126,0.2756
99,Tumor State 5,ONCOGENIC_CAHOY_ASTROGLIAL,0.0,0.0,0.0,0.0,0.1448,0.1879
100,Tumor State 5,ONCOGENIC_CAHOY_NEURONAL,0.0025,0.0034,0.0963,0.0882,0.2666,0.3175
102,Tumor State 5,ONCOGENIC_CAMP_UP.V1_DN,0.001,0.0087,0.0004,0.005,0.2126,0.2859
103,Tumor State 5,ONCOGENIC_CAMP_UP.V1_UP,0.0,0.0,0.0,0.0,0.2126,0.277
104,Tumor State 5,ONCOGENIC_CORDENONSI_YAP_CONSERVED_SIGNATURE,0.0,0.0,0.0,0.0,0.1448,0.1907
105,Tumor State 5,ONCOGENIC_CRX_DN.V1_DN,0.0003,0.0006,0.0001,0.0002,0.1678,0.2173
107,Tumor State 5,ONCOGENIC_CRX_NRL_DN.V1_DN,0.0091,0.0224,0.0069,0.0173,0.3973,0.4298
108,Tumor State 5,ONCOGENIC_CRX_NRL_DN.V1_UP,0.0514,0.0788,0.0452,0.0717,0.3973,0.4231
109,Tumor State 5,ONCOGENIC_CSR_EARLY_UP.V1_DN,0.0338,0.0477,0.0709,0.1011,0.1678,0.2085
110,Tumor State 5,ONCOGENIC_CSR_EARLY_UP.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
111,Tumor State 5,ONCOGENIC_CSR_LATE_UP.V1_DN,0.0351,0.0698,0.0296,0.0575,0.3973,0.3914
112,Tumor State 5,ONCOGENIC_CSR_LATE_UP.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1965
114,Tumor State 5,ONCOGENIC_CTIP_DN.V1_UP,0.0309,0.0601,0.4472,0.4093,0.3973,0.4116
115,Tumor State 5,ONCOGENIC_CYCLIN_D1_KE_.V1_DN,0.0068,0.0157,0.0031,0.0119,0.1678,0.2231
116,Tumor State 5,ONCOGENIC_CYCLIN_D1_KE_.V1_UP,0.0001,0.0006,0.0001,0.0004,0.2666,0.3274
117,Tumor State 5,ONCOGENIC_CYCLIN_D1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
118,Tumor State 5,ONCOGENIC_CYCLIN_D1_UP.V1_UP,0.0052,0.0128,0.0041,0.0082,0.2126,0.2859
120,Tumor State 5,ONCOGENIC_DCA_UP.V1_UP,0.0212,0.0294,0.0406,0.0529,0.4426,0.4298
121,Tumor State 5,ONCOGENIC_E2F1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1678,0.2266
122,Tumor State 5,ONCOGENIC_E2F1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2413
123,Tumor State 5,ONCOGENIC_E2F3_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
124,Tumor State 5,ONCOGENIC_E2F3_UP.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
125,Tumor State 5,ONCOGENIC_EGFR_UP.V1_DN,0.0001,0.0002,0.0001,0.0002,0.1678,0.2024
126,Tumor State 5,ONCOGENIC_EGFR_UP.V1_UP,0.0,0.0001,0.0,0.0001,0.1448,0.1879
127,Tumor State 5,ONCOGENIC_EIF4E_DN,0.0141,0.0117,0.0105,0.0114,0.2666,0.3184
128,Tumor State 5,ONCOGENIC_EIF4E_UP,0.0211,0.0456,0.0087,0.0348,0.2666,0.3336
129,Tumor State 5,ONCOGENIC_ERBB2_UP.V1_DN,0.0001,0.0004,0.0,0.0001,0.2666,0.3196
130,Tumor State 5,ONCOGENIC_ERBB2_UP.V1_UP,0.0,0.0,0.0,0.0,0.2126,0.2783
132,Tumor State 5,ONCOGENIC_ESC_J1_UP_EARLY.V1_UP,0.0882,0.1211,0.0368,0.0732,0.3492,0.372
133,Tumor State 5,ONCOGENIC_ESC_J1_UP_LATE.V1_DN,0.0001,0.0002,0.0,0.0001,0.1448,0.1907
134,Tumor State 5,ONCOGENIC_ESC_J1_UP_LATE.V1_UP,0.0151,0.016,0.0069,0.008,0.3973,0.4049
135,Tumor State 5,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
136,Tumor State 5,ONCOGENIC_ESC_V6.5_UP_EARLY.V1_UP,0.0,0.0,0.0,0.0,0.2126,0.2742
137,Tumor State 5,ONCOGENIC_ESC_V6.5_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
138,Tumor State 5,ONCOGENIC_ESC_V6.5_UP_LATE.V1_UP,0.0025,0.0023,0.0011,0.0019,0.2126,0.2665
140,Tumor State 5,ONCOGENIC_GCNP_SHH_UP_EARLY.V1_UP,0.0,0.0001,0.0,0.0,0.1678,0.2458
141,Tumor State 5,ONCOGENIC_GCNP_SHH_UP_LATE.V1_DN,0.0,0.0,0.0,0.0,0.1678,0.2117
142,Tumor State 5,ONCOGENIC_GCNP_SHH_UP_LATE.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2458
143,Tumor State 5,ONCOGENIC_GLI1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1907
144,Tumor State 5,ONCOGENIC_GLI1_UP.V1_UP,0.0295,0.047,0.0418,0.0622,0.3492,0.3861
145,Tumor State 5,ONCOGENIC_HINATA_NFKB_IMMU_INF,0.0,0.0,0.0003,0.0011,0.1448,0.1907
146,Tumor State 5,ONCOGENIC_HINATA_NFKB_MATRIX,0.0,0.0,0.0001,0.0003,0.1448,0.1894
147,Tumor State 5,ONCOGENIC_HOXA9_DN.V1_DN,0.0,0.0,0.0,0.0,0.2126,0.2741
148,Tumor State 5,ONCOGENIC_HOXA9_DN.V1_UP,0.0006,0.002,0.0001,0.0006,0.1678,0.2231
149,Tumor State 5,ONCOGENIC_IL15_UP.V1_DN,0.0051,0.0053,0.0169,0.0291,0.3973,0.4149
150,Tumor State 5,ONCOGENIC_IL15_UP.V1_UP,0.0212,0.0646,0.0122,0.0479,0.2666,0.3336
151,Tumor State 5,ONCOGENIC_IL21_UP.V1_DN,0.0425,0.0979,0.2405,0.2023,0.4426,0.4298
152,Tumor State 5,ONCOGENIC_IL21_UP.V1_UP,0.0212,0.046,0.0149,0.0349,0.2666,0.3116
153,Tumor State 5,ONCOGENIC_IL2_UP.V1_DN,0.0323,0.0359,0.2205,0.1488,0.4426,0.4298
155,Tumor State 5,ONCOGENIC_JAK2_DN.V1_DN,0.0,0.0001,0.0,0.0003,0.2126,0.2665
164,Tumor State 5,ONCOGENIC_KRAS.600.LUNG.BREAST_UP.V1_UP,0.0001,0.0001,0.0086,0.0047,0.3973,0.3841
166,Tumor State 5,ONCOGENIC_KRAS.600_UP.V1_UP,0.0002,0.0005,0.0052,0.0063,0.3973,0.4063
167,Tumor State 5,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
168,Tumor State 5,ONCOGENIC_KRAS.AMP.LUNG_UP.V1_UP,0.0436,0.1157,0.0604,0.1444,0.2666,0.3196
169,Tumor State 5,ONCOGENIC_KRAS.BREAST_UP.V1_DN,0.0034,0.0023,0.0007,0.0006,0.3492,0.3532
170,Tumor State 5,ONCOGENIC_KRAS.BREAST_UP.V1_UP,0.0403,0.0575,0.1469,0.1056,0.4426,0.4298
171,Tumor State 5,ONCOGENIC_KRAS.DF.V1_DN,0.0018,0.0026,0.0006,0.0009,0.1448,0.1879
172,Tumor State 5,ONCOGENIC_KRAS.DF.V1_UP,0.0,0.0001,0.0,0.0,0.1448,0.1965
174,Tumor State 5,ONCOGENIC_KRAS.KIDNEY_UP.V1_UP,0.0211,0.0421,0.2206,0.2826,0.3973,0.3808
175,Tumor State 5,ONCOGENIC_KRAS.LUNG.BREAST_UP.V1_DN,0.0108,0.016,0.0067,0.0171,0.2126,0.2611
177,Tumor State 5,ONCOGENIC_KRAS.LUNG_UP.V1_DN,0.0212,0.0414,0.0034,0.0093,0.2126,0.2715
178,Tumor State 5,ONCOGENIC_KRAS.LUNG_UP.V1_UP,0.0322,0.0689,0.5002,0.5321,0.4426,0.4298
179,Tumor State 5,ONCOGENIC_KRAS.PROSTATE_UP.V1_DN,0.0204,0.0167,0.0019,0.0021,0.2666,0.3196
181,Tumor State 5,ONCOGENIC_LEF1_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
182,Tumor State 5,ONCOGENIC_LEF1_UP.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2199
183,Tumor State 5,ONCOGENIC_LTE2_UP.V1_DN,0.0709,0.1055,0.0378,0.0571,0.3973,0.3914
184,Tumor State 5,ONCOGENIC_LTE2_UP.V1_UP,0.002,0.0039,0.0034,0.0061,0.2126,0.2665
186,Tumor State 5,ONCOGENIC_MEK_UP.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1894
187,Tumor State 5,ONCOGENIC_MEL18_DN.V1_DN,0.0296,0.0541,0.0448,0.0688,0.4426,0.4298
188,Tumor State 5,ONCOGENIC_MEL18_DN.V1_UP,0.072,0.149,0.0056,0.0251,0.3492,0.3841
190,Tumor State 5,ONCOGENIC_MTOR_UP.N4.V1_UP,0.0,0.0,0.0,0.0,0.2666,0.3111
191,Tumor State 5,ONCOGENIC_MTOR_UP.V1_DN,0.0083,0.01,0.0099,0.0111,0.2126,0.281
192,Tumor State 5,ONCOGENIC_MTOR_UP.V1_UP,0.0004,0.0031,0.0008,0.0067,0.1678,0.2413
193,Tumor State 5,ONCOGENIC_MYC_UP.V1_DN,0.0001,0.0003,0.0004,0.0014,0.2126,0.2756
194,Tumor State 5,ONCOGENIC_MYC_UP.V1_UP,0.0191,0.0183,0.0078,0.0074,0.3492,0.3457
196,Tumor State 5,ONCOGENIC_NOTCH_DN.V1_DN,0.003,0.0093,0.0212,0.0474,0.3492,0.3768
197,Tumor State 5,ONCOGENIC_NOTCH_DN.V1_UP,0.0212,0.0441,0.145,0.2299,0.2666,0.3224
198,Tumor State 5,ONCOGENIC_NRL_DN.V1_DN,0.0239,0.0564,0.0478,0.1021,0.3492,0.3861
199,Tumor State 5,ONCOGENIC_NRL_DN.V1_UP,0.0068,0.0128,0.0049,0.0119,0.1678,0.2241
201,Tumor State 5,ONCOGENIC_P53_DN.V1_UP,0.0002,0.0007,0.0001,0.0003,0.2126,0.281
202,Tumor State 5,ONCOGENIC_P53_DN.V2_DN,0.0001,0.0004,0.0,0.0003,0.1678,0.2241
205,Tumor State 5,ONCOGENIC_PDGF_ERK_DN.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
206,Tumor State 5,ONCOGENIC_PDGF_UP.V1_DN,0.0027,0.0111,0.023,0.0602,0.1678,0.239
207,Tumor State 5,ONCOGENIC_PDGF_UP.V1_UP,0.0232,0.054,0.0109,0.0286,0.2666,0.3274
209,Tumor State 5,ONCOGENIC_PIGF_UP.V1_UP,0.0,0.0001,0.0,0.0,0.2126,0.2859
210,Tumor State 5,ONCOGENIC_PKCA_DN.V1_DN,0.0092,0.0156,0.004,0.0093,0.1448,0.1907
211,Tumor State 5,ONCOGENIC_PKCA_DN.V1_UP,0.0,0.0,0.0,0.0,0.1678,0.2085
213,Tumor State 5,ONCOGENIC_PRC1_BMI_UP.V1_UP,0.0225,0.0278,0.2993,0.251,0.4426,0.4298
214,Tumor State 5,ONCOGENIC_PRC2_EED_UP.V1_DN,0.0036,0.0147,0.0039,0.0161,0.3973,0.4063
215,Tumor State 5,ONCOGENIC_PRC2_EED_UP.V1_UP,0.0076,0.0148,0.0281,0.058,0.3492,0.374
216,Tumor State 5,ONCOGENIC_PRC2_EZH2_UP.V1_DN,0.0017,0.0033,0.0016,0.0029,0.1448,0.1965
217,Tumor State 5,ONCOGENIC_PRC2_EZH2_UP.V1_UP,0.0709,0.0489,0.1481,0.1119,0.4426,0.4298
219,Tumor State 5,ONCOGENIC_PRC2_SUZ12_UP.V1_UP,0.0001,0.0004,0.0011,0.0038,0.3973,0.4063
220,Tumor State 5,ONCOGENIC_PTEN_DN.V1_DN,0.0001,0.0004,0.0,0.0,0.3973,0.4298
221,Tumor State 5,ONCOGENIC_PTEN_DN.V1_UP,0.0173,0.0228,0.0016,0.0036,0.1678,0.2085
224,Tumor State 5,ONCOGENIC_RAF_UP.V1_DN,0.0,0.0,0.0,0.0,0.1678,0.2024
225,Tumor State 5,ONCOGENIC_RAF_UP.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
226,Tumor State 5,ONCOGENIC_RAPA_EARLY_UP.V1_DN,0.0,0.0,0.0,0.0,0.2666,0.3184
227,Tumor State 5,ONCOGENIC_RAPA_EARLY_UP.V1_UP,0.025,0.0293,0.015,0.0124,0.3973,0.4043
228,Tumor State 5,ONCOGENIC_RB_DN.V1_DN,0.0,0.0,0.0,0.0,0.1678,0.2231
229,Tumor State 5,ONCOGENIC_RB_DN.V1_UP,0.0,0.0001,0.0,0.0,0.2666,0.3111
230,Tumor State 5,ONCOGENIC_RB_P107_DN.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1879
231,Tumor State 5,ONCOGENIC_RB_P107_DN.V1_UP,0.0,0.0,0.0,0.0,0.2126,0.277
232,Tumor State 5,ONCOGENIC_RB_P130_DN.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1965
233,Tumor State 5,ONCOGENIC_RB_P130_DN.V1_UP,0.0006,0.0061,0.001,0.0084,0.3492,0.3545
234,Tumor State 5,ONCOGENIC_RELA_DN.V1_DN,0.0,0.0,0.0,0.0001,0.1448,0.1965
235,Tumor State 5,ONCOGENIC_RELA_DN.V1_UP,0.0092,0.028,0.0058,0.0128,0.2666,0.3184
236,Tumor State 5,ONCOGENIC_RPS14_DN.V1_DN,0.0,0.0001,0.0,0.0,0.1678,0.2413
237,Tumor State 5,ONCOGENIC_RPS14_DN.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
238,Tumor State 5,ONCOGENIC_SINGH_KRAS_DEPENDENCY_SIGNATURE,0.0019,0.0034,0.0193,0.0307,0.3492,0.3768
239,Tumor State 5,ONCOGENIC_SIRNA_EIF4GI_DN,0.0,0.0,0.0,0.0,0.1448,0.1907
240,Tumor State 5,ONCOGENIC_SIRNA_EIF4GI_UP,0.0,0.0,0.0,0.0,0.1448,0.1965
241,Tumor State 5,ONCOGENIC_SNF5_DN.V1_DN,0.0109,0.0237,0.0082,0.0283,0.2666,0.3184
242,Tumor State 5,ONCOGENIC_SNF5_DN.V1_UP,0.0,0.0,0.0,0.0,0.1448,0.1879
245,Tumor State 5,ONCOGENIC_STK33_DN,0.0019,0.0064,0.0017,0.0062,0.1678,0.2231
250,Tumor State 5,ONCOGENIC_STK33_UP,0.0297,0.0174,0.0498,0.026,0.4426,0.4298
251,Tumor State 5,ONCOGENIC_TBK1.DF_DN,0.0,0.0,0.0,0.0,0.1448,0.1965
252,Tumor State 5,ONCOGENIC_TBK1.DF_UP,0.0008,0.0045,0.0002,0.0013,0.2126,0.2859
253,Tumor State 5,ONCOGENIC_TBK1.DN.48HRS_DN,0.0006,0.0057,0.0,0.0006,0.1678,0.2413
254,Tumor State 5,ONCOGENIC_TBK1.DN.48HRS_UP,0.0,0.0,0.0,0.0,0.2126,0.2791
255,Tumor State 5,ONCOGENIC_TGFB_UP.V1_DN,0.0006,0.0012,0.0006,0.0014,0.1678,0.2024
257,Tumor State 5,ONCOGENIC_VEGF_A_UP.V1_DN,0.0,0.0,0.0,0.0,0.1448,0.1938
259,Tumor State 5,ONCOGENIC_WNT_UP.V1_DN,0.0073,0.0188,0.0028,0.0096,0.2126,0.2665
260,Tumor State 5,ONCOGENIC_WNT_UP.V1_UP,0.0116,0.0351,0.0459,0.1452,0.4426,0.4298
262,Tumor State 5,ONCOGENIC_YAP1_UP,0.0,0.0,0.0,0.0,0.2666,0.3184
